Wednesday, December 2, 2020
Home Life Style Health & Fitness Moderna COVID-19 Vaccine May Not Increase Risk of More Severe Disease: Study

Moderna COVID-19 Vaccine May Not Increase Risk of More Severe Disease: Study

Moderna's COVID-19 Vaccine Appears to Clear Safety Hurdle

A series of studies in mice of Moderna’s COVID-19 vaccine lent some assurance that it may not increase the risk of more severe disease, and that one dose may provide protection against the novel coronavirus, according to preliminary data released Friday as per COVID-19 Information & Resources.

Prior studies on a vaccine for SARS — a close cousin to the new virus that causes COVID-19 — suggests vaccines against this type of virus might have the unintended effect of causing more severe disease when the vaccinated person is later exposed to the pathogen, especially in individuals who do not produce an adequately strong immune response.

Scientists have seen this risk as a hurdle to clear before vaccines can be safely tested in thousands of healthy people.

Follow NewsGram on Instagram to keep yourself updated.

While the data released by the U.S. National Institutes of Allergy and Infectious Disease (NIAID) and Moderna offered some assurance, the studies do not fully answer the question.

“This is the barest beginning of preliminary information,” said Dr. Gregory Poland, an immunologist and vaccine researcher at the Mayo Clinic who has seen the paper, which has yet to undergo peer review.

Poland said the paper was incomplete and disorganized and that the numbers of animals tested were small.

The authors said they have submitted the work to a top-tier journal. Moderna’s vaccine is in midstage testing in healthy volunteers. Moderna said Thursday that it plans to begin final-stage trials enrolling 30,000 people in July.

Moderna COVID-19 vaccine lent some assurance
A man stands outside an entrance to a Moderna building in Cambridge, Massachusetts, May 18, 2020. VOA

In the animal studies, mice received one or two shots of a variety of doses of Moderna’s vaccine, including doses considered not strong enough to elicit a protective immune response. Researchers then exposed the mice to the virus.

Subsequent analyses suggest “sub-protective” immune responses do not cause what is known as vaccine-associated enhanced respiratory disease, a susceptibility to more severe disease in the lungs.

“Subprotective doses did not prime mice for enhanced immunopathology following [exposure],” Dr. Barney Graham of the Vaccine Research Center at NIAID and colleagues wrote in the manuscript, posted on the bioRxiv website.

Further testing suggested the vaccine induces antibody responses to block the virus from infecting cells.

The vaccine also appeared to protect against infection by the coronavirus in the lungs and noses without evidence of toxic effects, the team wrote.

They noted the mice that received just one dose before exposure to the virus seven weeks later were “completely protected against lung viral replication,” suggesting a single vaccination prevented the virus from replicating in the lungs.

Moderna COVID-19 vaccine lent some assurance
The vaccine induces antibody responses to block the virus from infecting cells. (Representative Image). Pixabay

Also Read: Six Things You Need to Know About the COVID-19 Pandemic

“At first glance, it looks promising in inducing neutralizing antibody protection in mice,” Dr. Peter Hotez, a researcher at Baylor College of Medicine, said in an email. He had not reviewed the paper in detail.

Poland, who was not involved with the research, said the paper leaves out “important parameters” that could help scientists judge the work.

“The results, such as they are presented, provide interesting data that are reassuring. … This needs to be replicated and it needs to be peer-reviewed,” he said. (VOA)



Most Popular

Chinese Spacecraft To Bring Lunar Soil From Moon

China's Chang'e-5 mission, intended to bring back around 2 kg of lunar soil and rocks to the earth, touched down on the Moon on...

America’s Favorite Snacks Invented By US Military

From instant coffee to Cheetos, packaged cookies, and energy bars, the U.S. military helped invent many of the snacks Americans love to eat. The effort...

COVID Pandemic Obstructed Global Fight Against AIDS

Tuesday is World AIDS Day, with organizations around the world highlighting the need to support those living with and affected by HIV, the virus...

Focus on Having Healthy Heart To Face COVID

Amid the rising cases of Covid-19 in Delhi-NCR, health experts on Tuesday stressed that along with a focus on overall health, taking special care...

Enchanting Tale On Impact of Social Media

This is among the first books to explore the psychological impact of social media, especially Instagram. Garv Roy Gill and Yahvi Kothari meet by chance...

Book on Range of Issues in India By Ram Madhav

For the last few decades, Ram Madhav, formerly the national General Secretary of the Bharatiya Janata Party (BJP), has been observing and participating in...

Short Film Based On Digital Detox Streaming On OTT

Signal, a short film that highlights how digital detox is the need of the hour, has now dropped on OTT. The 32-minute film revolves...

LVB Write-off To Hurt Investor Sentiments of Smaller Banks

The write-off of Lakshmi Vilas Bank's (LVB) debt is likely to hurt investor sentiment toward lower-rated and smaller Indian banks, which would push up...

Recent Comments